CNBC's Huckman On Weight Loss/Diabetes Drug

Tuesday, 5 Dec 2006 | 1:18 PM ET

We're keeping an eye on shares of Sanofi-Aventis . The company says a new study finds its acomplia weight loss drug can also help diabetes. CNBC's pharmaceutical reporter Mike Huckman had the details on "Squawk on the Street."

Huckman says acomplia could help control type 2 diabetes--and that test results also showed the raising of good cholesterol-by up to 16%. The drug could provide up to $5 billion dollars in sales revenues. The drug helps weight loss by curbing the appetite.

There's also another possibility for acomplia. Sanofi-Aventis might consider further tests with the drug to help stop smoking.

  Price   Change %Change



  • Showtimes

    United States
    Monday - Friday 9a ET
    Monday - Friday 15:00 CET
    Monday - Friday 21:00 SIN/HK
    Monday - Friday 23:00 SYD
    New Zealand
    Tuesday - Saturday 01:00 NZ
  • Carl Quintanilla is an Emmy-winning reporter and co-anchor of CNBC's "Squawk on the Street," broadcast live from the NYSE.

  • Simon Hobbs co-anchors the 10 a.m. hour of CNBC's "Squawk on the Street" live from the New York Stock Exchange.

  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

  • Co-anchor of CNBC's "Squawk on the Street," David Faber also is a co-producer of CNBC's original documentaries.

  • Rick Santelli joined CNBC Business News as an on-air editor in 1999, reporting live from the floor of the Chicago Board of Trade.